Core Laboratory 
Core Laboratory 

Webinars


Access on demand presentations led by subject matter experts and Abbott key opinion leaders to gain insight into industry trends, medical discoveries, healthcare technologies and much more.


WATCH NOW. VISIT US FREQUENTLY FOR NEW CONTENT.

INFECTIOUS DISEASE 

 

 

Infectious Disease

IMPACT OF GLOBAL VIRAL SURVEILLANCE ON DIAGNOSTIC TOOLS

When disease-causing viruses (e.g. hepatitis B) mutate, there is a risk of being unable to detect them for diagnosis and monitoring, as well as the risk that the treatment response to current medications may be lessened. Therefore, viral genetic diversity has the potential to impact a vast number of healthcare touchpoints.

Abbott is constantly searching for new ways to improve people's health. A critical success factor involves monitoring retroviruses and hepatitis viruses from around the globe with a surveillance program, to help ensure laboratory tests continue to accurately detect divergent virsuses, regardless of where they are acquired. Since 1994, Abbott's Global Viral Surveillance Program has been at the forefront of viral surveillance continually  evolving to impact the development of next generation solutions.


    Speaker
    Portrait_Gavin_Cloherty_135x130.jpg
    Gavin A. Cloherty, PHD
    Head of Infectious Disease Research,  Abbott Diagnostics

    Gavin A. Cloherty, graduated from the National University of Ireland, Galway, where he received his Ph.D in molecular biology and a Bachelor of Science in microbiology and zoology. He provides scientific leadership in the area of infectious disease diagnostics by leading groundbreaking clinical studies on hepatitis and HIV. As one of the top experts in the field, his innovative research is changing the way infectious diseases are being diagnosed to help improve patient outcomes.

    Gavin has 20 years of experience with Abbott and leads a team of scientists in the study of HIV and hepatitis related discoveries, Gavin leads a team that recently identified unique hepatitis E recombinant strains in humans, uncovered unexpectedly high prevalence of hepatitis Delta in countries such as Cameroon, and identified strains of the newly discovered HPgV-2 in samples from around the world.

    Throughout his career Gavin has published numerous abstracts, posters, and manuscripts. He has established numerous partnerships with commercial organizations, ministries of health and government agencies, including the Centers for Disease Control and Prevention (CDC). He is a member of numerous professional and scientific societies, including the International AIDS Society and the American Association for the Study of Liver Disease. 
     
                           
     
    LEARNING OBJECTIVES
    • Understand the evolution of the Global Viral Surveillance Program and find out what's new
    • Discover the impact of viral surveillance on past, present and future laboratory diagnostic tools
    • Understand how you can get involved in the program

     

    WHO SHOULD WATCH
    • Laboratorians
    • Clinicians
     
    Back To Top

     

    Explore 


    knowledge-center-learning-guide_200x300.jpg

    Learning Guides

    Build key laboratory competencies and explore topics from various disciplines with our learning guides.

    Visit the Learning guides

    knowledge-center-crosslink_300x200.jpg

    Knowledge Center

    Find the latest information in laboratory science, therapeutic areas and Abbott innovation.

    Visit Knowledge Center  

    tvo-webinar-efficiency-image-300x200.jpg

    Webinar: Total Value of Ownership

    Watch the webinar to hear from experts how you can realize the value within and beyond your laboratory walls with a TVO approach. 

    Watch The Webinar 

    Back

    You are about to exit the Abbott family of websites for a 3rd party website

    Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

    Do you wish to continue and exit this website?

    Yes No

    You are about to enter an Abbott country or region specific website.

    Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

    Do you wish to continue and enter this website?

    Yes No

    DO YOU WISH TO CONTINUE AND EXIT THE CORE LABORATORY WEBSITE?

    Content is not under the control of corelaboratory.abbott.

    Yes No